Introduction
Mixed Mulleriam tumuor originate primarily in the endometrum or myometrium. Rarely, these tumours can also develop in the cervix and ovary 1 . Uterine carcinosarcoma is cancer that develops in the uterus, carcinoma signifies that, when looked at under a microscope, the tumour displays histological feature of both endometrial carcinoma and sarcoma. Endometrial carcinoma starts in the endometrium, while sarcoma begins in the myometrium of the uterus 2 . A rare cancer, uterine carcinocercoma makes up less than 5% of all uterine cancer 3 . In the USA, about 2 per 100000 women develop uterine carcinosarcoma annually 4 . Roughly only 35% of patients survive 5 years after diagnosis.
A case Report
Here we report a rare case of cervical tumour that was ECG-within normal limit USG of whole abdomen-a mass in the cervical region and others normal findings Broad spectrum antibiotic coverage was started on admission. Then patient was managed surgically, the total abdominal hysterectomy with bilateral salpingooophorectomy was done and specimen was sent for histopathology. The surgical findings were-no pelvic adhesions, both ovaries where normal as her age, body of the uterus was slightly enlarged and a big necrossed mass was in the cervical region that project through the vaginal canal. After operation the post operative period of the patient was good and the patient was discharged on 5th post operative day then she was followed up after 3 week with histopathological report, she was well but her report was Malignant Mixed Mullerial Tumour that is carcinosarcoma. Then she was counseled and referred to oncology department of this institute for better management. Now she is under treatment of chemotherapy in cancer centre of Khwaja Yunus Ali Medical College & Hospital and she is well.
Discussion
Carcinosarcomas are malignant tumours that consist of a mixture of carcinoma or epithelial cancer and sarcoma or mesenchymal or connective tissue cancer 5 .
Carcinosarcomas are tumours can arise in diverse organs, such as the skin, salivary glands, lungs, esophagus, pancreas, colon, uterus ovaries 5, 6, 7, 8, 9, 10, 11 .
Four man hypotheses have been proposed for the cellular origin of carcinosarcoma, based largely on the pathology of the diseases 5, 7 . First, the collision of two independent tumours resulting in a single neoplasm, based on the observation that skin cancer and superficial malignant fibrous histocytomas are commonly seen in patients with sun-damaged skin, second, the composition hypothesis, which suggests that the masenchymal component represents a pseudosarcomatous reaction to the epithelial malignancy, third, the combination hypothesis, which suggests that both the epithelial and mesenchymal components of the tumour arises from a common pluripotential stem cell that undergoes divergent differentiation and fourth, the conversion or divergence hypothesis, which argues that the sarcomatous component of the tumour represents a metaplastic sarcomatous transformation of the epithelial component. Despite the rinsing uncertainty on the mechanisms that generate these tumours, recent immuno-histochemical, ultrastructural and molecular genetic studies suggest and favor the notion monoclonality in carcinosarcoma 5, 7 . In addition, identical p53 and KRAs mutations have been identified in both epithelial and mesenchymal components of carcinosarcoma, findings that suggest an early alteration in the histogenesis of the tumour with late transformation or degeneration of the eplithelial component into the sarcomatous component 7 .
Conclusion
Carcinosarcoma of the uterus is a highly aggressive form of uterine cancer. As its name implies, this is a biphasic tumour which contains an admixture of carcinoma and sarcoma. Endometrium is the most common site, these tumours tend to occur in post menopausal women although rarely are reported in younger women. Uterine carcinosarcomas generally have a worse or poor prognosis compared to uterine carcinomas with five years survival rate ranging from 5% to 40%, the most important prognostic factor is tumour stage. The main treatment is surgery to remove the cancer, however, because of the high rate of both local and distant recurrence after surgery, and then the effective adjuvant chemotherapies are needed. In addition, radiotherapy to the abdomen is not associated with improved survival.
